Elixinol Global Limited (ASX:EXL)
Elixinol Global Limited (ASX:EXL) is a global leader in the hemp-derived CBD industry, researching, developing, marketing and selling Elixinol-branded, hemp-derived full and broad spectrum CBD products. Its operations are focused on the following markets:
Established in 2014 and based in Colorado, the group is an established market player with a strong brand reputation for quality and innovation. The group's focus is building its Elixinol consumer brand portfolio via its experienced manufacturing, R&D, sales and marketing teams across the US and Latin America.
Europe & UK
Having entered the European markets in 2018, the group enjoys an early mover advantage as a trusted global broad and full spectrum CBD brand. The group's primary focus is on expanding its already extensive Elixinol brand footprint in UK and Germany consumer channels, whilst setting a benchmark for quality and transparency. Based in Utrecht, The Netherlands
As an Australian publicly listed company, the group's Global Executive office is based here with a focus on providing strategic oversight, unified planning, governance and investor relations on behalf of the group. Based in Sydney, Australia.
The group are also proud owners of one of Australia’s most established hemp foods brands with the award-winning Hemp Foods Australia. Located near Byron Bay, NSW, Hemp Foods Australia produces and distributes hemp-based food products.
Rest of World
Long established in South Africa and Japan via 3rd party distribution and licensing agreements, the group is continuously expanding distribution of Elixinol branded hemp-derived CBD products through reputable distributors as key markets open